Aims-To identify the histological changes in leprosy skin lesions over the first few weeks after the start of leprosy treatment and to examine their relationship to reversal reaction. Methods-Sequential skin biopsy during treatment with multiple drug therapy. In this study, a series of 28 patients was studied, from whom two or more biopsies were taken at two week intervals. Fourteen patients had paucibacillary leprosy (PBL) and 14 had multibacillary leprosy (MBL). Results-In most cases, granuloma fraction and bacterial index fell during treatment, the bacterial index being less sensitive than the granuloma fraction. Since the biopsies were fixed in buffered formalin and processed through to paraffin wax, little immunohistochemistry was feasible. However, there was strong evidence of immune activation, with increased expression of HLA-DR in the granulomas of MBL and PBL cases: the epidermis also expressed HLA-DR in several patients. Such changes may reflect yIFN production from granuloma lymphocytes. Patients with reversal reaction often showed HLA-DR expression on admission which decreased with corticosteroid treatment.
Abstract
Aims-To identify the histological changes in leprosy skin lesions over the first few weeks after the start of leprosy treatment and to examine their relationship to reversal reaction. Methods-Sequential skin biopsy during treatment with multiple drug therapy. In this study, a series of 28 patients was studied, from whom two or more biopsies were taken at two week intervals. Fourteen patients had paucibacillary leprosy (PBL) and 14 had multibacillary leprosy (MBL) . Results-In most cases, granuloma fraction and bacterial index fell during treatment, the bacterial index being less sensitive than the granuloma fraction. Since the biopsies were fixed in buffered formalin and processed through to paraffin wax, little immunohistochemistry was feasible. However, there was strong evidence of immune activation, with increased expression of HLA-DR in the granulomas of MBL and PBL cases: the epidermis also expressed HLA-DR in several patients. Such changes may reflect yIFN production from granuloma lymphocytes. Patients with reversal reaction often showed HLA-DR expression on admission which decreased with corticosteroid treatment. The biopsies were fixed in 4% buffered form- Lysozyme was present to some degree in at least one biopsy in all patients except one with lepromatous leprosy. It was visually stronger in patients with tuberculoid/borderline-tuberculoid leprosy and reversal reaction. In the four reversed reaction patients on corticosteroids, lysozyme expression appeared to diminish with time, while in four of eight and two of six MBL newly diagnosed patients, it appeared to increase. Lysozyme staining was often patchy within the cell and was unsuitable for image analysis.
Conclusions
Three of the patients (two borderline-tuberculoid, one borderline lepromatous) were given prednisolone therapy on admission as they were thought to be in reaction: all three showed HLA-DR and lysozyme expression in their first biopsy, which declined or showed little change in subsequent biopsies. Clinical follow up of the patients after three years showed that three out of 20 newly diagnosed or relapsed patients had developed reactions, including two patients without initial evidence of reaction whose HLA-DR staining increased considerably following treatment; HIA staining was not performed in the remaining case as the granuloma fraction was <4%. Two patients moved away and were lost of follow up.
Discussion
This study has confirmed that the granuloma fraction falls more quickly than the bacterial index after treatment starts, and that it may increase in some patients with histological evidence of reaction.2 There is also evidence of increased lysozyme expression in newly detected patients treated with multiple drug treatment for one month, and of a rapid reduction in lysozyme expression in those patients on corticosteroid treatment for reversal reaction. However, the most striking observation is the increase in HLA-DR, which is some patients occurs within two weeks of starting treatment. This dramatic rise in expression of a class II antigen presentation molecule is strong evidence of an increase in macrophage/epitheloid cell activation. '6 17 it is possible that the reversal reaction represents a clinically identifiable degree of an immunological process which occurs in all patients treated for leprosy.
Larger studies are required to confirm these preliminary results, and to correlate them with immunological variables'5 and markers ofnerve or vascular function.'8"' The ability to follow immunological changes within the granuloma quantitatively by sequential biopsy, immunohistochemistry, and image analysis should be considered as a tool for use in future clinical trials of modified multiple drug treatment regimens in leprosy.
